A Novel Competing-Risk Model Integrating Systemic Inflammation to Predict Acute-on-Chronic Liver Failure
Clinical and Molecular Hepatology · 17.11.2026
DOI: 10.3350/cmh.2026.0766 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 17.11.2026. Verfasst von Heechul Nam und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Uijeongbu St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
Abstract (Originalsprache)
Background/Aims: Absolute risk of acute-on-chronic liver failure (ACLF) can be overestimated when the hazards of competing events, such as liver transplantation (LT) or death without ACLF, are not incorporated. We developed and validated a novel competing-risk-based model integrating systemic inflammation to predict ACLF development.
Methods
The derivation cohort comprised 1,146 patients with acute decompensation of cirrhosis from the prospective, multicenter Korean Acute-on-Chronic Liver Failure (KACLiF) cohort. External validation used a retrospective 1,104-patient cohort. The study followed the TRIPOD+AI reporting guidelines and applied a Fine-Gray subdistribution hazard model accounting for the competing risks of death or LT, with predictive performance evaluated using the C-index and time-dependent area under the receiver operating characteristic curve (AUROC).
Results
The KACLiF-ACLF score integrated C-reactive protein, albumin, total bilirubin, international normalized ratio, and creatinine. In derivation, the competing-risk C-index (0.806 at 28 days; 0.791 at 90 days) significantly exceeded all eight comparators at 90 days, but not MELD or MELD-Na at 28 days. In external validation, it (0.892 and 0.889) significantly exceeded all comparators at both horizons. Time-dependent AUROCs at 28 days were 0.815 and 0.894, significantly exceeding all comparators at both horizons except MELD-Na at 28 days in derivation. Transported absolute risks were overpredicted, requiring recalibration. The model stratified patients into low-, intermediate-, and high-risk groups, correlating with cumulative ACLF incidence and transplant-free survival (P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Uijeongbu St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
- Department of Internal Medicine, Bucheon St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.
- Department of Internal Medicine, Korea University Ansan Hospital, Ansan, Korea.
- Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea.
- Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea.
- Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.
Zitieren
APA
Nam, H., Kim, H. Y., Jung, Y. K., Yim, H. J., Kim, T. H., Yoon, E. L., Kim, J. H., Kim, S. E., Suk, K. T., Kim, D. J., Yoo, J. J., Kim, S. G., Kim, M. Y., Chang, Y., Jeong, S. W., Jang, J. Y., Park, J. G., Kim, W., Song, D. S., & Korean Acute-on-Chronic Liver Failure (KACLiF) study group (2026). A Novel Competing-Risk Model Integrating Systemic Inflammation to Predict Acute-on-Chronic Liver Failure. Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0766
Vancouver
Nam H, Kim HY, Jung YK, Yim HJ, Kim TH, Yoon EL, et al. A Novel Competing-Risk Model Integrating Systemic Inflammation to Predict Acute-on-Chronic Liver Failure. Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.0766
BibTeX
@article{Nam2026,
author = {Nam, Heechul and Kim, Hee Yeon and Jung, Young Kul and Yim, Hyung Joon and Kim, Tae Hyung and Yoon, Eileen L and Kim, Jung-Hee and Kim, Sung-Eun and Suk, Ki Tae and Kim, Dong Joon and Yoo, Jeong-Ju and Kim, Sang Gyune and Kim, Moon Young and Chang, Young and Jeong, Soung Won and Jang, Jae Young and Park, Jung Gil and Kim, Won and Song, Do Seon and Korean Acute-on-Chronic Liver Failure (KACLiF) study group, Korean Acute-on-Chronic Liver Failure (KACLiF) study group},
title = {A Novel Competing-Risk Model Integrating Systemic Inflammation to Predict Acute-on-Chronic Liver Failure},
journal = {Clinical and Molecular Hepatology},
year = {2026},
doi = {10.3350/cmh.2026.0766}
}
EUVIMED